Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Progressing the care, husbandry and management of ageing mice used in scientific studies.

Wilkinson MJ, Selman C, McLaughlin L, Horan L, Hamilton L, Gilbert C, Chadwick C, Flynn JN.

Lab Anim. 2019 Aug 12:23677219865291. doi: 10.1177/0023677219865291. [Epub ahead of print]

PMID:
31403890
2.

Minimizing Propionibacterium acnes contamination in shoulder arthroplasty: use of a wound protector.

Smith ML, Gotmaker R, Hoy GA, Ek ET, Carr A, Flynn JN, Evans MC.

ANZ J Surg. 2018 Nov;88(11):1178-1181. doi: 10.1111/ans.14821. Epub 2018 Sep 21.

PMID:
30239085
3.

Cohesion fatigue induces chromatid separation in cells delayed at metaphase.

Daum JR, Potapova TA, Sivakumar S, Daniel JJ, Flynn JN, Rankin S, Gorbsky GJ.

Curr Biol. 2011 Jun 21;21(12):1018-24. doi: 10.1016/j.cub.2011.05.032. Epub 2011 Jun 9.

4.

Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited.

Potapova TA, Sivakumar S, Flynn JN, Li R, Gorbsky GJ.

Mol Biol Cell. 2011 Apr 15;22(8):1191-206. doi: 10.1091/mbc.E10-07-0599. Epub 2011 Feb 16.

5.

Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.

Dunham SP, Bruce J, Klein D, Flynn JN, Golder MC, MacDonald S, Jarrett O, Neil JC.

Vaccine. 2006 Nov 30;24(49-50):7095-108. Epub 2006 Jul 18.

PMID:
17049683
6.

AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens.

Pistello M, Bonci F, Flynn JN, Mazzetti P, Isola P, Zabogli E, Camerini V, Matteucci D, Freer G, Pelosi P, Bendinelli M.

J Virol. 2006 Sep;80(18):8856-68.

7.

Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays.

Hofmann-Lehmann R, Tandon R, Boretti FS, Meli ML, Willi B, Cattori V, Gomes-Keller MA, Ossent P, Golder MC, Flynn JN, Lutz H.

Vaccine. 2006 Feb 20;24(8):1087-94. Epub 2005 Sep 19.

PMID:
16198454
8.

Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.

Flynn JN, Pistello M, Isola P, Zaccaro L, Del Santo B, Ricci E, Matteucci D, Bendinelli M.

Clin Diagn Lab Immunol. 2005 Jun;12(6):736-45.

9.

Development of antibodies to feline IFN-gamma as tools to elucidate the cellular immune responses to FeLV.

Graham EM, Jarrett O, Flynn JN.

J Immunol Methods. 2003 Aug;279(1-2):69-78.

PMID:
12969548
10.

Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection.

Flynn JN, Dunham S, Mueller A, Cannon C, Jarrett O.

Vet Immunol Immunopathol. 2002 Mar;85(3-4):159-70.

PMID:
11943317
11.

Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.

Dunham SP, Flynn JN, Rigby MA, Macdonald J, Bruce J, Cannon C, Golder MC, Hanlon L, Harbour DA, Mackay NA, Spibey N, Jarrett O, Neil JC.

Vaccine. 2002 Feb 22;20(11-12):1483-96.

PMID:
11858854
12.
13.

Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif.

Leutenegger CM, Boretti FS, Mislin CN, Flynn JN, Schroff M, Habel A, Junghans C, Koenig-Merediz SA, Sigrist B, Aubert A, Pedersen NC, Wittig B, Lutz H.

J Virol. 2000 Nov;74(22):10447-57.

14.
15.

Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.

Boretti FS, Leutenegger CM, Mislin C, Hofmann-Lehmann R, K├Ânig S, Schroff M, Junghans C, Fehr D, Huettner SW, Habel A, Flynn JN, Aubert A, Pedersen NC, Wittig B, Lutz H.

AIDS. 2000 Aug 18;14(12):1749-57.

PMID:
10985311
16.

Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination.

Flynn JN, Hosie MJ, Rigby MA, Mackay N, Cannon CA, Dunsford T, Neil JC, Jarrett O.

Vaccine. 2000 Jan 6;18(11-12):1118-32.

PMID:
10590334
17.
18.

DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.

Hosie MJ, Flynn JN, Rigby MA, Cannon C, Dunsford T, Mackay NA, Argyle D, Willett BJ, Miyazawa T, Onions DE, Jarrett O, Neil JC.

J Virol. 1998 Sep;72(9):7310-9. Erratum in: J Virol 1998 Oct;72(10):8460.

20.

FIV infection of the domestic cat: an animal model for AIDS.

Willett BJ, Flynn JN, Hosie MJ.

Immunol Today. 1997 Apr;18(4):182-9. Review. No abstract available.

PMID:
9136455
21.
22.

Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.

Flynn JN, Keating P, Hosie MJ, Mackett M, Stephens EB, Beatty JA, Neil JC, Jarrett O.

J Immunol. 1996 Oct 15;157(8):3658-65.

PMID:
8871667
23.

Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.

Flynn JN, Beatty JA, Cannon CA, Stephens EB, Hosie MJ, Neil JC, Jarrett O.

AIDS Res Hum Retroviruses. 1995 Sep;11(9):1107-13.

PMID:
8554908
25.

Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.

Flynn JN, Cannon CA, Beatty JA, Mackett M, Rigby MA, Neil JC, Jarrett C.

J Virol. 1994 Sep;68(9):5835-44.

26.

Involvement of gamma delta T cells in immunity to trypanosomiasis.

Flynn JN, Sileghem M.

Immunology. 1994 Sep;83(1):86-92.

27.

Generation of monoclonal antibodies to the anti-trypanosomal drug isometamidium.

Peregrine AS, Eisler MC, Katende J, Flynn JN, Gault EA, Kinabo LD, Holmes PH.

Hybridoma. 1994 Aug;13(4):289-94.

PMID:
7806249
28.

Polyclonal B-cell activation in cats infected with feline immunodeficiency virus.

Flynn JN, Cannon CA, Lawrence CE, Jarrett O.

Immunology. 1994 Apr;81(4):626-30.

29.

Modulation of the phenotype and function of bovine afferent lymph cells during infection with Trypanosoma congolense.

Flynn JN, McKeever DJ, Sileghem M, Naessens J.

Vet Immunol Immunopathol. 1994 Jan;40(1):17-29.

PMID:
8128607
31.

Immunosuppression in trypanotolerant N'Dama cattle following Trypanosoma congolense infection.

Flynn JN, Sileghem M.

Parasite Immunol. 1993 Sep;15(9):547-52.

PMID:
7877852
32.
33.

Detection and neutralization of bovine tumor necrosis factor by a monoclonal antibody.

Sileghem M, Saya R, Ellis JA, Flynn JN, Peel JE, Williams DJ.

Hybridoma. 1992 Oct;11(5):617-27.

PMID:
1459585
36.

Modulation of T-cell reactivity to synthetic peptide analogues of foot-and-mouth disease virus in sheep by amino acid substitutions.

Flynn JN, Harkiss GD, Moore D, DiMarchi R.

Vet Immunol Immunopathol. 1992 Mar;31(3-4):255-66.

PMID:
1375405
37.

Suppression of T-cell responsiveness during tsetse-transmitted trypanosomiasis in cattle.

Sileghem M, Flynn JN.

Scand J Immunol Suppl. 1992;11:37-40.

PMID:
1355308
38.
40.

Supplemental Content

Loading ...
Support Center